SCHEMBL6871202

SCHEMBL6871202

Cc1[c]cc(C)n1Cc1cccs1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.44
▸ TSHR P16473 4/20 0.44
▸ HSD17B10 Q99714 4/20 0.44
▸ SMN1; SMN2 Q16637 4/20 0.44
▸ HPGD P15428 3/20 0.44
▸ KDM4E B2RXH2 3/20 0.44
▸ CYP1A2 P05177 4/20 0.41
▸ CYP3A4 P08684 4/20 0.41
▸ USP2 O75604 3/20 0.41
▸ CYP2D6 P10635 3/20 0.41
▸ CYP2C19 P33261 3/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ RAB9A P51151 6/20 0.40
▸ NPC1 O15118 5/20 0.40
▸ ALDH1A1 P00352 5/20 0.40
▸ HTT P42858 3/20 0.40
▸ LMNA P02545 3/20 0.39
▸ TP53 P04637 1/20 0.39
▸ CYP2C9 P11712 2/20 0.39
▸ CASP1 P29466 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL266418 0.71 RAB9A (0.54) MAPTTSHRHSD17B10SMN1; SMN2HPGD
SCHEMBL9369418 0.68 MEN1 (0.47) MAPTTSHRHSD17B10SMN1; SMN2HPGD
SCHEMBL15987441 0.65 RAB9A (0.66) MAPTTSHRHSD17B10SMN1; SMN2HPGD
SCHEMBL17544480 0.64 CYP1A2 (0.43) MAPTTSHRHSD17B10SMN1; SMN2HPGD
SCHEMBL448303 0.62 HTT (0.50) MAPTTSHRHSD17B10HPGDKDM4E
SCHEMBL18346214 0.61 TAAR1 (0.43) MAPTHSD17B10SMN1; SMN2HPGDCYP2C19
SCHEMBL10646248 0.61 HTT (0.48) MAPTTSHRHSD17B10SMN1; SMN2HPGD
SCHEMBL7654044 0.61 HTT (0.68) MAPTTSHRHSD17B10SMN1; SMN2KDM4E
SCHEMBL91161 0.60 — —
SCHEMBL7050984 0.60 HTT (0.72) MAPTTSHRHSD17B10SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1388535-A1 Acylated arylcycloalkylamines and their use as pharmaceuticals Aventis Pharma Deutschland GmbH (DE) 2004-02-11 — — EP disclosed
Send feedback